Treatment With Nefecon Reduces Circulating Levels of Galactose-Deficient IgA1 in Patients With IgA Nephropathy in the NefIgArd Clinical Trial: SA-PO654

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2022-11, Vol.33 (11S), p.783-784
Main Authors: Molyneux, Karen, Nawaz, Nadia, Taylor, Scott, Barratt, Jonathan
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1046-6673
DOI:10.1681/ASN.20223311S1783d